1.0000
0.0000
(0.00%)
At close: January 24 at 3:00:00 PM EST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Shlomo Pilo | CEO & Director | 244k | -- | 1955 |
| Mr. Guy Ofir | General Counsel, CFO & Director | 144k | -- | 1973 |
| Dr. Igal Louria Hayon | CTO & Director | -- | -- | 1973 |
Raphael Pharmaceutical Inc.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops product candidate for the treatment of rheumatoid arthritis and hyper inflammatory syndrome inflammation related to COVID-19. It also intends to develop product candidate to treat oncology indications. The company is headquartered in Tel Aviv-Jaffa, Israel.
Corporate Governance
Raphael Pharmaceutical Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
September 24, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
Related Tickers
TRA.VN Traphaco Joint Stock Company
76,900.00
0.00%
526075.BO 526075.BO,0P0000BXCE,0
4.5000
0.00%
AX9.SG Akebia Therapeutics Inc
2.2580
-0.88%
6CQ.BE Cresco Labs Inc
0.8830
+4.07%
R9U2.F Green Thumb Industries Inc.
6.67
-0.67%
BON.SG Boiron SA
25.20
-3.63%
AX9.F Akebia Therapeutics, Inc.
2.2020
-1.87%
NECLIFE.BO Nectar Lifesciences Limited
36.65
-4.98%
STSN Stemsation International, Inc.
0.0060
-1.64%
APPH.DE Apontis Pharma AG
10.40
+1.96%